Persistent Treatment Effect Achieved at One Year After 4 Doses of Fel d 1-Derived Peptide Immunotherapy in an Environmental Exposure Chamber (EEC) Model of Cat Allergy
Hafner, R.P, Efthimiou, J, Salapatek, A, Patel, D, Larche, M
Published in Journal of allergy and clinical immunology (01.02.2012)
Published in Journal of allergy and clinical immunology (01.02.2012)
Get full text
Journal Article
Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes
Hafner, R.P, Salapatek, A, Patel, D, Larché, M, Laidler, P
Published in Journal of allergy and clinical immunology (01.02.2012)
Published in Journal of allergy and clinical immunology (01.02.2012)
Get full text
Journal Article
Suppression of Allergic Airway Inflammation by Low Dose, Intranasally Administered Der p 1 Derived Peptides, in a Murine Model of House Dust Mite Allergy
Moldaver, D.M, Bharhani, M.S, Wattie, J, Hafner, R.P, Inman, M, Larche, M
Published in Journal of allergy and clinical immunology (01.02.2012)
Published in Journal of allergy and clinical immunology (01.02.2012)
Get full text
Journal Article
Development and Preliminary Clinical Evaluation of a Peptide Immunotherapy Vaccine for Cat Allergy
Larché, M, Lee, H, Kleine-Tebbe, J, Hafner, R.P, Laidler, P, Healey, D, Buhot, C, Verhoef, A, Maillère, B, Kay, A.B, Worm, M
Published in Journal of allergy and clinical immunology (01.02.2011)
Published in Journal of allergy and clinical immunology (01.02.2011)
Get full text
Journal Article